We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Stephen J. Freedland, MD

Associate Director, Faculty Development Samuel Oschin Comprehensive Cancer Institute

Co-Director, Cancer Genetics and Prevention Program

Director, Center for Integrated Research in Cancer and Lifestyle

Professor, Surgery

Warschaw Robertson Law Families Chair in Prostate Cancer

Steven Spielberg Building, Room 192
8723 Alden Drive
Los Angeles, CA 90048

Phone:

310-423-4700

Fax:

310-423-4711

Parking Instructions:

Parking is available in Lot 2.

Stephen J. Freedland, MD

Associate Director, Faculty Development Samuel Oschin Comprehensive Cancer Institute

Co-Director, Cancer Genetics and Prevention Program

Director, Center for Integrated Research in Cancer and Lifestyle

Professor, Surgery

Warschaw Robertson Law Families Chair in Prostate Cancer

  • Urology

Enlarged Prostate (BPH)

Nutrition Counseling

Prostate Cancers

Prostate Diseases

Prostatectomy

Urinary Incontinence in Men

Urinary Retention

Stephen Freedland, MD, is director of the Center for Integrated Research in Cancer and Lifestyle, co-director of the Cancer Genetics and Prevention Program and associate director for Faculty Development at the Samuel Oschin Comprehensive Cancer Institute. He is a faculty physician in the Division of Urology at the Cedars-Sinai Department of Surgery. Freedland's clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia and prostate cancer. His approach toward cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional Western medicine with complementary holistic interventions. His research interests include urological diseases and the role of diet, lifestyle and obesity in prostate cancer development and progression, as well as prostate cancer among racial groups and risk stratification for men with prostate cancer. Freedland has published over 400 studies, and his research has appeared in the Journal of the American Medical Association, Journal of the National Cancer Institute, Journal of Clinical Oncology, Journal of Urology, Cancer Prevention Research, Cancer and BJUI, among others. Freedland is an active reviewer for more than 50 journals. He sits on the editorial board for Cancer Prevention Research, European Urology, International Journal of Urology, Nature Reviews Urology and BJUI, and serves as editor-in-chief for Prostate Cancer and Prostatic Diseases and as a consulting editor for European Urology. Freedland earned his MD from the University of California, Davis. He completed a residency in urology at UCLA and a fellowship in urological oncology at Johns Hopkins. Before joining Cedars-Sinai, he was at Duke University, where he specialized in surgical oncology and urologic oncology, and served as an associate professor in the Division of Urology.

View NIH Biographical Sketch as a PDF

  • Undergraduate: UCLA, 1993
  • Medical School: University of California, Davis, 1997
  • Residency: UCLA, 2003

View CV as a PDF

  • Who's Who in Medicine and Healthcare, 2003-present
  • Editor-in-Chief: Prostate Cancer and Prostatic Diseases, 2010-present
  • Who's Who in America, 2011-present

Click here for a list of peer-reviewed publications.

  • Lin PH, Aronson WJ, Freedland SJ. Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med. 2015;13:3.
  • Freedland SJ. The effect of diet and supplements on prostate cancer. Clin Adv Hematol Oncol. 2014;12(8):538-540.
  • Lin PH, Freedland SJ. Lifestyle and lower urinary tract symptoms: what is the correlation in men? Curr Opin Uro. 2015; 25(1):1-5.
  • Freedland SJ, Choeurng V, Howard L, De Hoedt A, du Plessis M, Yousefi K, Lam LL, Buerki C, Ra S, Robbins B, et al. Utilization of a genomic classifier for prediction of metastasis following salvage radiation therapy after radical prostatectomy. Eur Urol. 2016 Jan 21. [Epub ahead of print].
  • Simon RM, Howard LE, Moreira DM, Roehrborn C, Vidal AC, Castro-Santamaria R, Freedland SJ. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial. Eur Urol. 2015 Dec 24/. [Epub ahead of print].
  • Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ. Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study. Clin Cancer Res. 2015;21(4):756-762.

Show moreShow less

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Stephen J. Freedland, MD